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Abstract
Objective: Increased penetration of pulsatile power to the brain has been implicated in the 
pathogenesis of age-related cognitive dysfunction and dementia, a common comorbidity in 
patients with heart failure and preserved ejection fraction (HFpEF). However, there is a lack of 
knowledge on the effects of organic and inorganic nitrates administration in this population on the 
power carried by pressure and flow waves traveling through the proximal aorta and penetrating the 
carotid artery into the brain microvasculature.
Approach: We assessed aortic and carotid hemodynamics non-invasively in two sub-studies: (1) 
at baseline and after administration of 0.4 mg of sublingual nitroglycerine (an organic nitrate; n = 
26); and (2) in a randomized controlled trial of placebo (PB) versus inorganic nitrate 
administration (beetroot-juice (BR), 12.9 mmol NO3; n = 16).
Main results: Wave and hydraulic power analysis demonstrated that NTG increased total 
hydraulic power (from 5.68% at baseline to 8.62%, P = 0.001) and energy penetration (from 
8.69% to 11.63%;P = 0.01) from the aorta to the carotid, while inorganic nitrate administration did 
not induce significant changes in aortic and carotid wave power (power: 5.49%PB versus 
6.25%BR, P = 0.49; energy: 8.89%PB versus 10.65%BR, P = 0.27).
Significance: Organic nitrates, but not inorganic nitrates, increase the amount of hydraulic 
energy transmitted into the carotid artery in subjects with HFpEF. These findings may have 
implications for the adverse effect profiles of these agents (such as the differential incidence of 
headaches) and for the pulsatile hemodynamic stress of the brain microvasculature in this patient 
population.
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Introduction
Heart failure (HF) affects approximately 6.5 million adults in the United States, with its 
prevalence rising to ⩾10% among persons 70 years of age or older (Benjamin et al 2017). 
Approximately half of patients with HF have a preserved left ventricular (LV) ejection 
fraction (HFpEF) (Udelson 2011). Patients with HFpEF demonstrate increased arterial 
stiffness and pulsatile arterial load, including increased late systolic pressure augmentation 
from arterial wave reflections arriving at the LV during systole (Weber et al 2008).
Pharmacological treatment of HFpEF aims at lowering ventricular load, with nitrates, both 
in organic and inorganic form, being part of the therapeutic arsenal. Organic nitrates have 
been shown to reduce arterial load to the LV after acute administration (Heart Failure 
Society of America 2006, Hunt et al 2009), but they are also associated with a high 
incidence of side effects such as headache, dizziness and hypotension in patients with 
HFpEF, and recent trials failed to demonstrate a clinical benefit in this population (Zamani et 
al 2016, 2017). In contrast to available data with organic nitrates, several recent studies have 
demonstrated that inorganic nitrate improves hemodynamics in HFpEF and has not been 
associated with a high incidence of headache or important reductions in blood pressure 
(Zamani et al 2015, Eggebeen et al 2016).
In a recent study (Chirinos et al 2017), we found that the acute administration of organic 
nitrates has a profound effect on carotid hemodynamics, with a marked reduction in carotid 
bed vascular resistance and dilation of the carotid artery, which may account for the high 
incidence of headaches and dizziness, respectively. The effects of vasoactive drugs on 
cerebrovascular hemodynamics, however, may be relevant beyond acute side effects such as 
headache. Accumulating evidence links increased penetration of pulsatile energy (power) to 
the brain, with the development and/or progression of cognitive dysfunction and dementia 
(Mitchell et al 2011, Chirinos et al 2013), which are common comorbidities in the HFpEF 
population. The brain is a high-flow, low-resistance organ, in which the microvasculature is 
more directly exposed to the pulsatility that occurs in central arteries. Although organic 
nitrates reduce central pulse pressure in HFpEF (Chirinos et al 2017), the marked associated 
cerebrovascular vasodilatory effect, with reduction of carotid characteristic impedance and 
carotid bed vascular resistance, may actually facilitate pulsatile power penetration into the 
brain microvasculature, potentially undermining the beneficial effects of these drugs on 
central pulse pressure. The effects of organic nitrates on power penetration to the brain have 
not been previously assessed, nor have these effects been compared with the effects of 
inorganic nitrates.
The aim of this study is therefore to quantify and characterize the patterns of hydraulic 
power carried by waves traveling through the proximal aorta and the carotid artery, and the 
effects of organic and inorganic nitrates on these parameters among patients with HFpEF.
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Methods
The present work is based on previous studies of organic (Chirinos et al 2017) and inorganic 
nitrates (Zamani et al 2015) in HFpEF, here referred to as sub-studies 1 and 2. In sub-study 
1, aortic and carotid hemodynamics were assessed non-invasively at baseline and after the 
administration of 0.4 mg of sublingual Nitroglycerine (NTG), an organic nitrate. In sub-
study 2, aortic and carotid pressure-flow data was analyzed from a PB-controlled 
randomized trial of inorganic nitrate administration (nitrate-rich beetroot juice) in HFpEF 
(Zamani et al 2015). Protocols were approved by the University of Pennsylvania and 
Philadelphia Veterans Affairs (VA) Medical Center Institutional Review Boards, as 
appropriate. All subjects provided written informed consent before enrollment. Inclusion 
and exclusion criteria are described in detail elsewhere (Zamani et al 2015, Chirinos et al 
2017).
Study protocol
Sub-study 1—Twenty-six participants were included in this protocol. After at least 10 min 
of rest in the supine position, BP was taken on the right arm with a validated oscillometric 
device (Omron HEM-705CP, Omron Corporation, Kyoto, Japan). For echocardiographic and 
Doppler ultrasound assessments, a GE-e9 ultrasound machine (GE Healthcare; Fairfield, 
CT) equipped with a cardiac and vascular probe was used. Pulsed wave Doppler 
measurements of flow velocities in the LV outflow tract were performed and recorded 
placing the Doppler sample immediately proximal to the aortic valve leaflets within the 
centerline of the LV outflow tract, and its cross-sectional area was computed from the radius 
(r) measured in the parasternal long axis view (area = πr2). Carotid diameter and blood 
velocity were acquired using a vascular linear probe.
Carotid artery applanation tonometry was performed using a SphygmoCor CPV System 
(AtCor Medical Inc, Itasca, IL) that operates with a high-fidelity applanation tonometer 
(Millar Instruments; Houston, TX). Aortic pressure waveforms are only obtainable through 
invasive measurements, which is not applicable in clinical practice. Therefore, derived 
measurements should be used instead and, previously, it has been demonstrated that carotid 
pressure waveforms represent reasonable surrogates of the aortic pressure waveform (Chen 
et al 1996, Segers et al 2005). After baseline measurements were obtained, a single dose (0.4 
mg) of NTG was administrated sublingually, and measurements were repeated starting at 
least 2 min after administration. Comparisons were made between measurements obtained 
pre-versus post-NTG administration.
Sub-study 2—Seventeen subjects participated in a randomized, double-blind, crossover 
study of a single dose of inorganic nitrate given as concentrated nitrate-rich beetroot juice 
(BR) (NO3−, BEET IT Sport, James-White Drinks Ltd, Ipswich, UK) containing 12.9 mmol 
NO3
−
 in 140 ml versus an otherwise identical nitrate-depleted PB juice (James White Drinks, 
Ltd). There was a washout period of at least 5 d separating the interventions. Measurements 
of aortic and carotid hemodynamics were preformed using identical methods as in sub-study 
1, ~2.5 h after juice ingestion. Comparisons were made between measurements obtained 
after administration of nitrate-rich (BR) versus nitrate-depleted (PB) beetroot juice. One 
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subject was excluded from these analyses due to the lack of carotid flow data during one of 
the study visits.
Hemodynamic analyses
A custom-designed software was built in Matlab (The Mathworks, Natick, MA) (Segers et al 
2007, Chirinos et al 2009) to process off-line central arterial tonometry recordings and 
Doppler flow velocity files. Signal averaging was performed first, followed by the time 
alignment of both signals as previously described (Segers et al 2007, Nichols et al 2011). 
Hemodynamic analysis commonly assumes a parabolic or flat flow velocity profile to 
convert velocity measured in a sample volume into a volumetric flow. However, this 
simplification may be inadequate for the carotid artery, as the flow velocity profile is neither 
of both. We therefore implemented a conversion accounting for the Womersley number (a 
well-established dimensionless fluid-dynamics parameter for oscillatory flow), as previously 
described (Ponzini et al 2010).
Wave power analysis
Recently, Mynard et al (Mynard and Smolich 2016) introduced the concept of wave power 
as a means to analyse the energy carried by the incident and reflected pressure and flow 
waves. This technique finds its origin in wave intensity analysis but has the major advantage 
of allowing for a quantitative analysis of how the energy transmitted by the heart into the 
aorta is distributed over the arterial tree.
Figure 1 shows a graphical depiction of wave power analysis. After digitally re-sampling 
signals to 500 Hz for a more accurate time-alignment of pressure and flow, wave power (dπ) 
was defined as the product of the instantaneous changes in pressure and flow (dP * dQ). 
Wave power can be separated into the power carried by forward-traveling (dπ+) and 
backward-traveling (dπ
−
) waves:
dπ± = ±
1
4Zc
dP ± ZcdQ
2 (1)
where Zc = characteristic impedance (calculated in the frequency domain), and total power 
(dπ) equals the sum of power carried by forward (dπ+) and backward (dπ−) waves.
Wave power is a function of time and demonstrates two major positive peaks: a forward 
compression wave (FCW), generated by the contraction of the LV in early systole, and a 
forward expansion wave (FEW), generated as the rate of myocardial shortening is reduced in 
late systole (Penny et al 2008, Mynard and Smolich 2016). We report the area under the 
curve (AUC) of FCW (grey area) and FEW (light grey area) at the aorta and the carotid 
arteries, while the black area is the backward wave (figure 1(B)).
We also computed total hydraulic power which is related to the rate of energy production 
and expenditure in the cardiovascular system, as previously described (Mynard and Smolich 
2016). We calculated the AUC in total hydraulic power as the total energy transmitted from 
Londono-Hoyos et al. Page 4
Physiol Meas. Author manuscript; available in PMC 2018 December 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the heart to the aorta and to the carotid artery. We also computed the peak values of the total 
hydraulic power curve at both locations (figure 1(C)).
We computed the power penetration from the aorta into the carotid vascular circulation, as 
an index based on total hydraulic power parameters (peak power or energy as the AUC) as 
follows:
%Penetration =
Carotid Power Parameter
Aortic Power Parameter * 100. (2)
Statistical analysis
Descriptive data are presented as mean ± standard deviation (SD) for continuous variables or 
counts (%) for categorical variables. Comparisons between pre- and post-NTG values for 
sub-study 1, and between values corresponding to nitrate-rich (BR) versus nitrate-depleted 
(PB) beetroot juice administration for sub-study 2, were performed using paired t-tests. 
Physiologic indices were expressed as absolute values at each time point, as well as absolute 
differences between measurements (with 95% confidence intervals, CIs). Positive 
differences represent an increase in the values associated with organic/inorganic nitrate 
administration, whereas negative differences represent a decrease in such values. A two-
tailed P value < 0.05 was considered statistically significant. Statistical analyses were 
performed using SPSS v-21 for Windows (SPSS Inc., Chicago, IL).
Results
General characteristic parameters obtained from both sub-study populations are shown in 
table 1. The mean age of participants was 60 and 65 years in sub-studies 1 and 2, 
respectively. Consistent with the HFpEF phenotype, subjects in both studies were obese, had 
a high prevalence of hypertension and diabetes, as well as left atrial enlargement. Both 
sample populations were composed predominantly of males, with a high proportion of 
African-Americans. All subjects in both sub-studies had NYHA class II—III symptoms.
Sub-study 1: effects of organic nitrate
Parameters obtained from wave and hydraulic power analysis before and after NTG intake 
are summarized in table 2. Aortic and carotid FCW and FEWs were not significantly 
different after NTG administration. There was a reduction in the total aortic hydraulic power 
energy (1.53 J/beat to 1.35 J/beat, change: 11.8% decrease, P = 0.01) and a trend towards a 
decrease in peak hydraulic power (7.26 W to 6.59 W; change: 9.2% decrease, P = 0.06). In 
contrast, there was a significant increase in peak carotid hydraulic power (0.39 W to 0.54 W; 
change: +38.5% increase, P = 0.008) after NTG administration. Figure 2(A) demonstrates 
the post-NTG change in total hydraulic power parameters. The observed increase in carotid 
hydraulic power despite a reduced aortic hydraulic power implies an increase in the 
percentage of power transmission from the aorta into the carotid (peak total hydraulic power 
penetration: 5.68% versus 8.62%; P = 0.001; total hydraulic energy penetration: 8.69% 
versus 11.63%; P = 0.01, figure 3(A)).
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Sub-study 2: effects of inorganic nitrate
Table 2 displays the calculated wave and hydraulic power parameters for sub-study 2. No 
significant changes were found for aortic or carotid values between PB and beetroot intake. 
Figure 2(B) shows the percent difference in total hydraulic power parameters at the aorta and 
the carotid arteries in the BR intervention compared to the PB intervention. Figure 3(B) 
displays a comparison of the percent changes in power penetration parameters between these 
two conditions, demonstrating non-significant differences between these hemodynamic 
parameters after PB versus BR intake.
Discussion
In this study, we quantified the effect of organic and inorganic nitrates on pulsatile power 
penetration to the brain in patients with HFpEF. Administration of NTG, an organic nitrate, 
led to a significant reduction of aortic hydraulic power, an increase in power penetration to 
the carotid artery (due to cerebrovascular vasodilation), and an absolute increase in carotid 
hydraulic power. In contrast, inorganic nitrate administration did not induce significant 
changes in aortic and carotid wave power or percentage of power penetration. Our findings 
have important implications for our understanding of the cerebrovascular hemodynamic 
effects of organic and inorganic nitrates in this population, which in turn may have 
implications for the adverse effect profile of these drugs and cerebrovascular microvascular 
health.
In contrast to inorganic nitrate (Chirinos and Zamani 2016), organic nitrates result in 
undesirable side effects, such as pulsatile headache, flushing, hypotension or even syncope 
(Yaginuma et al 1986, Chirinos et al 2017). In particular, recent trials of organic nitrates in 
HFpEF have demonstrated poor tolerability, with a high incidence of side effects (Redfield 
et al 2015, Zamani et al 2016) and frequent discontinuation of long-term use (Zamani et al 
2017). The important incidence of headaches is possibly related to the increase on pulsatile 
power penetration to the cerebrovascular territory demonstrated in our study. However, the 
importance of this hemodynamic effect may extend beyond its role in headaches. Increased 
penetration of pulsatile power to the brain is progressively recognized as an important factor 
in the development of cognitive dysfunction and dementia (Mitchell et al 2011, Chirinos et 
al 2013), which are common comorbidities in the HFpEF population (Cannon et al 2015, 
Cermakova et al 2015). Due to its high blood flow needs, the brain vasculature is a low-
resistance bed, in which the microvasculature is more directly exposed to the pulsatility that 
occurs in conduit vessels. Therefore, the pulsatile power transmission from the aorta to the 
conduit branches that feed the cerebrovascular territory is a key determinant of pulsatile 
hemodynamics in the cerebrovascular microcirculation. We demonstrate, for the first time, 
that despite the reduction in blood pressure induced by NTG in HFpEF, the marked 
associated cerebrovascular vasodilatory effect actually leads to increased (rather than 
decreased) hydraulic power transmission into the carotid territory. In contrast, we 
demonstrate that inorganic nitrates do not increase pulsatile power penetration to the brain.
Nitrates/nitrites-related adverse events can limit compliance with these medications and have 
an undesired impact on various outcomes (such as outpatient physical activity) in HFpEF. 
Detailed assessments of their hemodynamic effects can contribute to elucidate the 
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mechanisms of these side effects. Given that the incidence of headaches has been reported to 
be greater with organic versus inorganic nitrates, our study focused on the differential effects 
of these agents on brain hemodynamics. However, we acknowledge that the relationship 
between our hemodynamic findings and the incidence of adverse events should be further 
investigated in future studies.
Our study should be interpreted in the context of its strengths and limitations. Strengths 
include the careful assessment of pulsatile carotid and aortic hemodynamics in an 
experimental design, using state-of-the-art non-invasive pressure-flow analyses. In 
particular, we implemented an ad hoc method to assess pulsatile power in the aorta and 
carotid arteries, as recently proposed by Mynard et al (Mynard and Smolich 2016). This 
method quantifies the distribution of wave power at junctions, is relatively insensitive to 
diameter variations, and is quantitatively linked to transient changes in hydraulic pressure 
power, a concept related to the rate of energy production and expenditure in the 
cardiovascular system. Additional strengths of our study include the use of identical 
methods to measure hemodynamics after organic and inorganic nitrate administration, 
facilitating the interpretation of differential hemodynamic effects. Our study also has several 
limitations. Our study samples were relatively small; however, the paired design of the 
studies greatly reduces measurement variability and allows for a robust assessment of the 
drug effects in each sub-study. However, our sub-studies represent post hoc analyses of two 
separate paired experiments, which prevents a direct comparison of the effects of organic 
versus inorganic nitrates. Both studies were performed as acute administration studies, and 
the chronic effects of these drugs on the patterns of power carried by waves traveling the 
aorta and the carotid artery could be different. Due to the characteristics of the patient 
population at the VA Medical Center, where subjects were primarily recruited, our study 
population was composed primarily of men.
We note that the hemodynamic effects reported herein for inorganic nitrate likely do not 
apply to shortacting inorganic nitrite preparations. Inhaled sodium nitrite, which is currently 
being studied in HFpEF, demonstrates markedly different pharmacokinetic properties 
compared to orally administered inorganic nitrate (Reddy et al 2017). The half-life of 
inhaled sodium nitrite is only ~35 min (Rix et al 2015), in contrast to several hours for 
inorganic nitrate (Kapil et al 2010), and intermittent inhaled administration is associated 
with pronounced circulating level fluctuations, which may cause hypotensive episodes in 
elderly patients with HFpEF. To our knowledge, no studies have been done assessing the 
cerebrovascular hemodynamic effects of sodium nitrite in HFpEF. Ongoing trials (the 
KNO3CK OUT HFpEF trial with orally administered potassium nitrate and the INDIE 
HFpEF trial with inhaled sodium nitrite (Reddy et al 2017)) will help clarify the side effect 
profiles and hemodynamic differences between inorganic nitrite and nitrate in this patient 
population.
In conclusion, to the extent of our knowledge, this study is the first to assess the effects of 
organic and inorganic nitrate on aortic and carotid wave and hydraulic power and energy in 
patients with HFpEF. Our study demonstrates that organic nitrates increase power 
penetration from the aorta into the carotid, which leads to a significant increase in carotid 
pulsatile hydraulic power, despite a reduction in aortic power. In contrast, inorganic nitrate 
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administration did not induce significant changes in aortic and carotid wave and hydraulic 
power or percentage of power penetration. These hemodynamic effects likely have 
implications for the pulsatile hemodynamic stress of the microvasculature of the brain. In the 
short term, these hemodynamic differences may contribute to the differential incidence of 
side effects (such as headaches) with organic versus inorganic nitrate therapy. In the long 
term, they may have implications for cognitive decline. However, the causal link between 
carotid pulsatile hemodynamics and cognitive decline, particularly in the setting of 
vasodilator therapy, requires further study.
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Figure 1. 
Graphical depiction of wave and hydraulic power analysis to illustrate steps and parameters 
extracted, including (A) tonometry (grey solid line) and ultrasound (black dotted line) 
signals alignment, and (B) wave power analysis (dπ), and (C) total hydraulic power analysis 
and selected parameters: area under the curve (Energy, grey area) and peak values (Power, 
black diamond). At left and right panels, aortic and carotid signals and curves are shown, 
respectively. Presented signals are pre-NTG. AUC = area under the curve; FCW = forward 
compression wave (grey area); FEW = forward expansion wave (light grey area); black 
represents the backward wave. * Indicates a statistically significant change (P < 0.05).
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Figure 2. 
Forest plots describing the change in percentage of selected parameters: after the 
administration of sublingual NTG (A) and between nitrate-depleted (PB) and nitrate-rich 
(BR) beet root juice intake (B). * Indicates a statistically significant change (P < 0.05)
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Figure 3. 
Percentage of carotid total hydraulic power penetration after the administration of sublingual 
NTG (A) and between nitrate-depleted (PB) and nitrate-rich (BR) beet root juice intake (B). 
* Indicates a statistically significant change against pre-NTG (3A) or PB (3B).
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Table 1.
General characteristics of participants (Chirinos et al 2017).
Variable Sub-study 1 (n = 26) Sub-study 2 (n = 16) P value
Age, median (IQR) 60 (56,65) 65 (62.5, 70.5) 0.10
Male, n (%) 20 (76.9) 14 (87.5) 0.68
Race 0.15
 African-American, n (%) 16 (61.5) 14 (87.5)
 Caucasian, n (%) 9 (34.6) 2 (12.5)
BMI(kg m−2), mean (SD) 36.5 (6.5) 34.4 (3.5) 0.24
Obesity (BMI > 30 kg m−2), n (%) 22 (84.6) 15 (93.8) 0.63
Current smoker, n (%) 4 (15.4) 1 (6.3) 0.63
Hypertension, n (%) 24 (92.3) 16 (100) 0.52
Diabetes, n (%) 17 (65.4) 11 (68.8) 0.82
Coronary artery disease, n (%) 8 (30.8) 3 (18.8) 0.49
Chronic kidney disease (eGFR < 60 ml min−1/1.73 m2) 9 (34.6) 5 (31.3) 0.82
Drug therapy, n (%)
 Beta blocker 14 (53.9) 10 (62.5) 0.58
 ACE-inhibitor/ARB 18 (69.2) 10 (62.5) 0.65
 Calcium-channel blocker 14 (53.9) 7 (43.8) 0.53
 Mineralocorticoid receptor antagonist 0 (0) 1 (6.3) 0.38
 Statin 15 (57.7) 9 (56.3) 0.93
 Aspirin 17 (65.4) 14 (87.5) 0.16
 Thiazide 14 (53.9) 4 (25.0) 0.07
 Loop diuretics 13 (50.0) 6 (37.5) 0.43
eGFRa (ml min−1/1.73 m2), median (IQR) 74.1 (53.5, 95.4) 65.5 (52.4, 89.5) 0.95
Left ventricular ejection fraction (%), median (IQR) 57.4 (55.0, 65.5) 62.4 (57.5, 69.8) 0.30
a
eGFR was calculated using the modification of diet in renal disease (MDRD) study equation.
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Table 2.
Aortic and carotid hemodynamics and power analysis before (Pre-) and after (Post-) administration of 
sublingual nitroglycerin (NTG) (sub-study 1) and after nitrate-depleted (PB) and nitrate-rich beet root juice 
administration (sub-study 2).
Sub-study 1 (organic nitrates) Sub-study 2 (inorganic nitrates)
Variable Pre-NTG Post-NTG P value Placebo Beet root juice P value
Hemodynamics
Central systolic pressure (mmHg) 133.57 (27.61) 120.50 (29.77) 0.01 130.03 (20.76 126.56 (24.23 0.50
Mean arterial pressure (mmHg) 96.82 (16.99) 90.54 (20.42) 0.02 97.56 (14.85) 96.44 (15.23) 0.70
Central pulse pressure (mmHg) 59.53 (23.60) 49.99 (19.38) 0.06 55.29 (16.75) 50.98 (17.96) 0.34
Central diastolic pressure (mmHg) 74.03 (15.41) 70.51 (15.25) 0.18 74.74 (12.55) 75.58 (9.80) 0.70
Cardiac output (1 min−1) 5.64 (1.40) 5.81 (1.23) 0.32 5.40 (1.42) 4.89 (1.15) 0.04
Stroke volume (ml) 90.41 (21.91) 89.07 (21.64) 0.65 83.58 (16.02) 78.71 (15.05) 0.07
Heart rate (bpm) 63.23 (10.82) 66.58 (11.06) 0.004 65.19 (12.78) 62.28 (10.39) 0.09
Peak aortic blood flow (cm3 s−1) 408.61 (100.90) 410.03 (103.16) 0.93 371.71 (64.88) 350.39 (65.71) 0.20
Mean aortic blood flow (cm3 s−1) 94.01 (23.31) 96.86 (20.42) 0.32 90.10 (23.59) 81.45 (19.12) 0.04
Peak carotid blood flow (cm3 s−1) 23.92 (15.35) 34.31 (21.51) 0.001 21.25 (11.62) 22.19 (13.51) 0.74
Mean carotid blood flow (cm3 s−1) 9.80 (6.73) 13.08 (8.38) 0.008 9.35 (5.24) 10.03 (6.91) 0.60
Carotid cross sectional area (cm2) 0.38 (0.09) 0.43 (0.1) <0.001 0.37 (0.08) 0.40 (0.12) 0.15
Aortic wave power analysis
FCWAUC (mJ) 0.129 (0.053) 0.117 (0.050) 0.26 0.107 (0.046) 0.093 (0.043) 0.31
FEWAUC (mJ) 0.041 (0.031) 0.032 (0.023) 0.17 0.036 (0.017) 0.033 (0.015) 0.53
Aortic hydraulic power analysis
Power (mW) 7256 (2549) 6591 (2204) 0.06 6666 (2165) 5845 (1846) 0.20
Energy (mJ) 1531 (511) 1351 (428) 0.01 1429 (447) 1275 (418) 0.18
Carotid wave power analysis
FCWAUC (mJ) 0.007 (0.006) 0.010 (0.011) 0.12 0.0056 (0.0040) 0.0049 (0.0027) 0.40
FEWAUC (mJ) 0.0014 (0.0014) 0.0018 (0.0020) 0.25 0.0014 (0.0009) 0.0011 (0.00045) 0.13
Carotid hydraulic power analysis
Power (mW) 387 (240) 536 (383) 0.008 356 (207) 351 (195) 0.91
Energy (mJ) 127 (78) 150 (84) 0.12 126 (76) 129 (68) 0.90
AUC = area under the curve; FCW = forward compression wave; FEW = forward expansion wave.
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